Topics › Health Sciences › Medicine › Infectious Diseases
HIV/AIDS drug development and treatment Sign in to save
Papers per year
23
24
26
Papers 4
Open in paper search →-
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
Alexandra Compagnucci, Man Kam Chan, Yacine Saïdi, Tim Roy Cressey, Alasdair Bamford, Yoann Riault, +69 more
17citations -
Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial
Amy E. Colson, Princy N. Kumar, Peter Jerome Ruane, Ploenchan Chetchotisakd, Winai Ratanasuwan, Afaaf Liberty, +91 more
3citations -
Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study2024 Open Forum Infectious Diseases article Medicine HIV/AIDS drug development and treatment Open access
Marta Vasylyev, Ferdinand W N M Wit, Carlijn C. E. Jordans, Robin Soetekouw, Steven F. L. van Lelyveld, Gert-Jan Kootstra, +20 more
1citations -
Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous–venous extracorporeal membrane oxygenation (VV‐ECMO): A case report2026 British Journal of Clinical Pharmacology article Medicine HIV/AIDS drug development and treatment Open access
Tom C. Zwart, Emiel Leegwater, Thomas H. Ottens, Schippers Ef, Erik B. Wilms, David Marinus Burger, +2 more
0citations
4 results
Most active Aachen authors
-
Anna H.E. Roukens 1,635 citations overall2 papers
-
Tim Niehues 12,026 citations overall1 paper
-
Tom C. Zwart 708 citations overall1 paper